Decoding Antibody Discovery — The Future of Next-Gen Biologics Webinar
The webinar "Decoding Antibody Discovery — The Future of Next-Gen Biologics," featuring experts Christian Olsen and Dr. Nimesh Joseph, explores current trends and innovative workflows in monoclonal antibody research and discovery to optimize early-stage biologics development, followed by a live Q&A session for attendee engagement.
Antibodies have established themselves as one of the most important classes within the biologics space, and developing these therapeutics requires a series of successful decisions throughout the early-discovery process. Antibody discovery is a complex and often circuitous route, which, if not efficiently optimized, can cost investigators valuable time and money. In this webinar, subject matter experts Christian Olsen and Dr. Nimesh Joseph provide an overview of current trends in monoclonal antibody research and discovery, and discuss how science and technology are converging to create cutting-edge workflows designed to drive innovation and breakthroughs in the largest biologics therapeutic class today.
A live Q&A session follows the presentations, offering attendees a chance to pose questions to the expert panelists.
Featured Speakers
- Christian Olsen, VP Strategy, Protein Therapeutics, Luma
- Nimesh Joseph, Senior Solution Engineer, Dotmatics
Nimesh Joseph is a trained cell and molecular biologist with over 20 years of research experience, primarily engaged in target validation studies across both academia and biotech. In his current role at Dotmatics, Nimesh oversees solution design for leading pharmaceutical and biotech research teams.
Event Details
- Date: Dec 13, 2022
- Time: 8:00am PDT / 11:00am EST / 17:00 CET
- Location: Online